Skip to main content
. 2007 Oct 17;2007(4):CD003167. doi: 10.1002/14651858.CD003167.pub3

Schulzer 1991.

Methods RCT. 
 Open label.
Participants 137 people with OHT. 
 Racial constitution is not reported. 
 Inclusion criteria: IOP above or equal to 22 mmHg, normal visual fields (Goldmann perimeter). 
 Exclusion criteria: Obvious sign of glaucomatous disc changes, ocular infections, trauma or surgery within 6 months before the study, resting pulse of 50 beats or less, systemic beta‐blockers.
Interventions Timolol 0.5% twice daily. 
 No treatment.
Outcomes Incidence of reproducible visual field defect. 
 Incidence of disc haemorrhages. 
 Incidence of stereophotographically documented optic nerve changes.
Notes 6 years follow up. 
 22 drop‐outs: 12 timolol (2 adverse drug reaction) and 10 untreated. The reasons for drop‐out are not specified.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear